Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Peter Lynch Fair Value applies to growing companies. The ideal range for the growth rate is between 10 - 20% a year. Peter Lynch thinks that the fair P/E value for a growth company equals its growth rate, that is PEG = 1. The earnings here is trailing twelve month (TTM) earnings. For non-bank companies, the growth rate we use is the average growth rate for EBITDA per share over the past 5 years. For Banks, the growth rate we use is the average growth rate for Book Value per share over the past 5 years. If 5-Year Growth Rate is greater than 25% a year, we use 25. If 5-Year Growth Rate is smaller than 5% a year, we do not calculate Peter Lynch Fair Value.
Here, as of today, Raaj Medisafe India's PEG is 1. Raaj Medisafe India's 5-Year TTM EBITDA Growth Rate is 19.51.
Raaj Medisafe India's EPS without NRI for the trailing twelve months (TTM) ended in Jun. 2026 was ₹2.00. Therefore, the Peter Lynch Fair Value for today is ₹39.02.
The historical rank and industry rank for Raaj Medisafe India's Peter Lynch Fair Value or its related term are showing as below:
BOM:524502'
s Price-to-Peter-Lynch-Fair-Value Range Over the Past 10 Years
Min: 0.52 Med: 1.09 Max: 2.56
Current: 2.56
During the past 13 years, the highest Price to Peter Lynch Fair Value Ratio of Raaj Medisafe India was 2.56. The lowest was 0.52. And the median was 1.09.
BOM:524502's Price-to-Peter-Lynch-Fair-Value is ranked worse than 79.82% of 114
companies
in the Packaging & Containers industry
Industry Median: 1.125
vs BOM:524502: 2.56
Note: Please don't confuse Peter Lynch Fair Value with the value reached in Peter Lynch Chart.
Raaj Medisafe India (BOM:524502) Peter Lynch Fair Value Explanation
Peter Lynch Fair Value applies to growing companies. The ideal range for the growth rate is between 10 - 20% a year.
Peter Lynch thinks that the fair P/E value for a growth company equals its growth rate, that is PEG = 1. The earnings here is trailing twelve month (TTM) earnings. For non-bank companies, the growth rate we use is the average growth rate for EBITDA per share over the past 5 years. For Banks, the growth rate we use is the average growth rate for Book Value per share over the past 5 years.
Please don't confuse Peter Lynch Fair Value with the value reached in Peter Lynch Chart. In Peter Lynch chart, a fixed P/E ratio of 15 is used to draw the Earnings Line. Therefore the value reached has a P/E ratio of 15. But in Peter Lynch Fair Value calculation, P/E equals to the growth rate of EBITDA per share over the past 5 years, which is 19.51 instead of 15 in this case.
Raaj Medisafe India's Price to Peter Lynch Fair Value Ratio for today is calculated as
Price to Peter Lynch Fair Value
=
Share Price
/
Peter Lynch Fair Value
=
99.85
/
39.02
=
2.56
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Raaj Medisafe India Peter Lynch Fair Value Related Terms
Raaj Medisafe India Peter Lynch Fair Value Historical Data
* Premium members only.
The historical data trend for Raaj Medisafe India's Peter Lynch Fair Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:524502 vs SW, AMCR, PKG: Peter Lynch Fair Value Comparison
For the Packaging & Containers subindustry, Raaj Medisafe India's Price-to-Peter-Lynch-Fair-Value, along with its competitors' market caps and Price-to-Peter-Lynch-Fair-Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Raaj Medisafe India Price-to-Peter-Lynch-Fair-Value vs Packaging & Containers Industry
For the Packaging & Containers industry and Consumer Cyclical sector, Raaj Medisafe India's Price-to-Peter-Lynch-Fair-Value distribution charts can be found below:
* The bar in red indicates where Raaj Medisafe India's Price-to-Peter-Lynch-Fair-Value falls into.
Raaj Medisafe India's EPS without NRI for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹2.00.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
** Please be aware that the 5-Year TTM EBITDA Growth Rate is calculated based on TTM data over the last 5 years. For quarterly reported companies, the TTM data adds up the quarterly data reported by the company within the most recent 12 months. For companies that report semi-annually, annually, or do not have enough quarterly data, GuruFocus uses the annual data as the TTM data.
If 5-Year Earnings Growth Rate is greater than 25% a year, we use 25.
If 5-Year Earnings Growth Rate is smaller than 5% a year, we do not calculate Peter Lynch Fair Value.
Please note that we use the 5-year average growth rate of EBITDA per share as the growth rate for non-bank companies, as EBITDA growth is subject to less manipulations than net earnings per share. For banks, we use the 5-year average growth rate of Book Value per share as the growth rate. The reason is that EBITDA is not applicable to Banks and Book value is a relative important measurement for Banks. In the calculation, PEG=1 because Peter Lynch thinks that the fair P/E ratio of the growth stock is equal to its earnings growth rate.
What does a Peter Lynch Fair Value of ₹39.02 mean?
Raaj Medisafe India (BOM:524502) has a Peter Lynch Fair Value of ₹39.02 as of Sep. 15, 2026. Peter Lynch Fair Value is the stock value based on a company's current earnings and five-year earnings growth, assuming a PEG of one. View historical data on Raaj Medisafe India and its competitors. According to the industry distribution chart, Raaj Medisafe India ranks #91 out of 114 companies in the Packaging & Containers industry, placing it in the top 79.8%.
Is Raaj Medisafe India's Peter Lynch Fair Value too high?
Raaj Medisafe India's current Peter Lynch Fair Value is ₹39.02. Based on the distribution chart, Raaj Medisafe India ranks #91 out of 114 companies in the Packaging & Containers industry, which is in the bottom quartile relative to peers. Overall, Raaj Medisafe India has a GF Score™ of 65/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Raaj Medisafe India's Peter Lynch Fair Value compare to SW and AMCR?
According to the Packaging & Containers industry distribution chart, Raaj Medisafe India ranks #91 out of 114 companies for Peter Lynch Fair Value. This places Raaj Medisafe India in the lower half of its industry. The industry median Peter Lynch Fair Value is 1.13. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Peter Lynch Fair Value for a Packaging & Containers company?
The median Peter Lynch Fair Value among Packaging & Containers companies is 1.13, based on 114 companies in the industry. Companies in the top quartile (top 25%) have a Peter Lynch Fair Value significantly above this median, while those in the bottom quartile fall well below. However, Peter Lynch Fair Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Peter Lynch Fair Value mean?
A high Peter Lynch Fair Value can signal that a stock is expensive relative to its fundamentals. Peter Lynch Fair Value is the stock value based on a company's current earnings and five-year earnings growth, assuming a PEG of one. View historical data on Raaj Medisafe India and its competitors. For the Packaging & Containers industry, the median Peter Lynch Fair Value is 1.13 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Raaj Medisafe India's current Peter Lynch Fair Value is ₹39.02. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Raaj Medisafe India stock overvalued right now?
Based on GuruFocus' analysis, Raaj Medisafe India (BOM:524502) is currently considered Fairly Valued. The stock's GF Value™ is ₹104.19, compared to a current price of ₹99.85 — trading 4.2% below its estimated fair value. The current Peter Lynch Fair Value is ₹39.02. Raaj Medisafe India's overall GF Score™ is 65/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Peter Lynch Fair Value calculated?
Peter Lynch Fair Value is calculated from a company's financial statements. For Raaj Medisafe India (BOM:524502), the current Peter Lynch Fair Value is ₹39.02 as of Sep. 15, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Raaj Medisafe India (BOM:524502) Overvalued in 2026?
Based on GuruFocus' analysis, Raaj Medisafe India stock appears to be undervalued.
The current stock price of ₹99.85 is trading 4.2% below its estimated GF Value™ of ₹104.19.
GuruFocus considers Raaj Medisafe India to be Fairly Valued.
Key valuation signals for BOM:524502:
Peter Lynch Fair Value: ₹39.02
GF Value™: ₹104.19 vs. price of ₹99.85 (4.2% below fair value)
No single metric tells the full story. See the BOM:524502 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Raaj Medisafe India Ltd is an India-based company engaged in manufacturing and selling plastic bottles, caps, plugs, aluminum caps, plastic liners, and related products. The firm operates in two segments: Plastic and HHygiene. The Company earns revenue mainly from the sale of packaging items.
65GF Score
Get the complete analysis for BOM:524502
Peter Lynch Fair Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:524502 has been successfully added to your 
